BMY Change in Working Capital

Bristol Myers Squibb · Change in Working Capital

BMY logo

BMY Change in Working Capital

Latest reported-$2.23B
BMY Change in Working Capital (-$624.00M → -$2.23B)
High-resolution chart · PNG

BMY change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-455,000,000
810,000,000
-1,914,000,000
-2,229,000,000
-1,261,000,000
983,000,000
3,170,000,000
217,000,000
2,145,000,000
-1,152,000,000
-735,000,000
242,000,000
194,000,000
-631,000,000
46,000,000
-29,000,000
42,000,000
117,000,000
-158,000,000
-640,000,000
-904,000,000
-600,000,000
-754,000,000
-2,142,000,000
1,083,000,000
-795,000,000
-542,000,000
-783,000,000
-1,353,000,000
-676,000,000
-987,000,000
-637,000,000
-209,000,000
-549,000,000
-474,000,000
-363,000,000
-624,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.